{"id":"stiripentol-oral-capsule","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Somnolence"},{"rate":"10-20%","effect":"Dizziness"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL1983350","moleculeType":"Small molecule","molecularWeight":"234.29"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It does this by increasing the activity of GABA_A receptors, which are responsible for the inhibitory effects of the neurotransmitter GABA. This results in a decrease in neuronal excitability and a reduction in the frequency and severity of seizures.","oneSentence":"Stiripentol is an antiepileptic drug that works by enhancing the inhibitory effects of GABA.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:36:30.016Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seizure control in Dravet syndrome"}]},"trialDetails":[{"nctId":"NCT07176832","phase":"PHASE1","title":"Bioavailability of Stiripentol After Single Oral Dose of Capsule vs Suspension in Healthy Subjects (STILIQ)","status":"COMPLETED","sponsor":"Biocodex","startDate":"2025-06-01","conditions":"Dravet Syndrome, Epilepsy, Childhood","enrollment":24},{"nctId":"NCT06465472","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3","status":"NOT_YET_RECRUITING","sponsor":"Biocodex","startDate":"2024-08","conditions":"Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 2, Primary Hyperoxaluria Type 3","enrollment":42}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Stiripentol Oral Capsule","genericName":"Stiripentol Oral Capsule","companyName":"Biocodex","companyId":"biocodex","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Stiripentol is an antiepileptic drug that works by enhancing the inhibitory effects of GABA. Used for Seizure control in Dravet syndrome.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}